TL;DR: The omega-3 index expresses EPA and DHA as a percentage of total fatty acids in your red blood cell membranes. Because red cells turn over slowly, it reflects your intake over roughly the previous three to four months rather than what you ate yesterday, which makes it a far better measure than a plasma fatty acid snapshot. Observational evidence linking higher omega-3 status to lower cardiovascular and all-cause mortality is reasonably consistent across cohorts. The problem is that randomised trials of omega-3 supplementation have largely failed to reproduce that benefit. VITAL, ASCEND, and a large Cochrane review all landed on essentially neutral results for supplementation in general populations. REDUCE-IT is the notable exception and remains contested, partly because of its mineral oil comparator. The most defensible reading: omega-3 status is a decent marker of a dietary pattern that includes fish, and eating fish is associated with better outcomes, but taking a fish oil capsule does not appear to replicate that. Testing your index is inexpensive and interesting. It is unlikely to change what you should do, which is to eat fish.
What is the omega-3 index and how does it work?
The omega-3 index is a specific, defined measurement: the combined amount of eicosapentaenoic acid and docosahexaenoic acid, expressed as a percentage of the total fatty acids in red blood cell membranes. It was developed and popularised by researchers including William Harris and Clemens von Schacky in the mid-2000s as a proposed cardiovascular risk marker.
The reason it uses red blood cells rather than plasma is the important design choice. Plasma fatty acids fluctuate with your last meal. If you had salmon last night, your plasma looks great this morning, which tells you nothing about your habitual status. Red blood cell membranes incorporate fatty acids over the cell's lifespan, and red cells live around 120 days. So the membrane composition integrates your intake over months. This is structurally the same logic as HbA1c using glycated haemoglobin to integrate glucose exposure, and it works for the same reason.
EPA and DHA are the long-chain marine omega-3s. They are not the same as ALA, alpha-linolenic acid, which is the plant omega-3 found in flaxseed, walnuts, and rapeseed oil. Humans can convert ALA to EPA and then to DHA, but the conversion is inefficient, generally estimated in the low single-digit percentages for the DHA step, and it is lower in men than in women. This is why vegetarians and vegans typically have a lower omega-3 index despite adequate ALA intake, and why algae-derived EPA and DHA exist as a supplement category. Our post on plant-based diets and longevity touches on this.
The index is one of the better-designed nutritional biomarkers. Whether a well-designed marker of something that turns out not to be causally important is worth measuring is the harder question, and we will come to it.
What is a good omega-3 index?
The proposed target range from the researchers who developed the measure is 8 to 12 percent, with below 4 percent characterised as an undesirable zone and 4 to 8 percent as intermediate. These cut points came from observational work relating red cell omega-3 content to cardiovascular risk, notably analyses associating higher membrane EPA and DHA with lower risk of sudden cardiac death.
Some context on those numbers. Populations with very high fish intake, Japan being the standard example, typically have index values in the region of 8 to 11 percent. Typical Western populations sit considerably lower, often in the range of 4 to 6 percent, and vegetarians and vegans are frequently below 4 percent. The target range is essentially "eat like a traditional Japanese diet".
Two honest caveats about the 8 to 12 percent target. First, it derives from observational associations, and as the trial section below explains, the interventional evidence has not supported the assumption that moving your index into that range by supplementing reduces your risk. A target derived from observational data does not automatically become a treatment goal. Second, the researchers who defined the index have had commercial interests in the test. That is not disqualifying, and it is normal for the people who develop a measurement to commercialise it, but it is relevant context when a specific numerical target is being promoted.
There is a related measure, the AA:EPA ratio, and various omega-6 to omega-3 ratio metrics. The ratio framing has been popular in wellness content but is on weaker ground than the index itself, because absolute levels of each fatty acid appear to matter more than their proportion, and because the "omega-6 is inflammatory" narrative is considerably more contested than its confident presentation suggests. Linoleic acid, the main dietary omega-6, is associated with lower rather than higher cardiovascular risk in most cohort studies.
Does a higher omega-3 index mean you live longer?
The observational evidence says probably, the trial evidence says probably not, and reconciling them is the whole story.
On the observational side, pooled analyses of prospective cohorts have found that people with higher circulating or red cell EPA and DHA have lower rates of cardiovascular events and lower all-cause mortality. Work from consortia pooling multiple cohorts has reported this reasonably consistently, and the associations survive standard adjustment. Fish consumption itself shows a similar pattern across many cohorts, which we cover in fish, omega-3, and cardiovascular lifespan.
On the trial side, the picture is much less flattering. VITAL, a large randomised trial in the United States, tested marine omega-3 supplementation and vitamin D in a general population and found no significant reduction in its primary cardiovascular endpoint or in cancer. ASCEND tested omega-3 supplementation in people with diabetes and found no benefit on serious vascular events. A Cochrane review of omega-3 supplementation, covering a large body of randomised evidence, concluded that increasing long-chain omega-3 intake through supplements has little or no effect on all-cause mortality or cardiovascular events, with the evidence for that conclusion rated as moderate to high certainty.
That Cochrane conclusion is the single most important sentence in this article, and it is worth sitting with. This is not a case of insufficient evidence. It is a case of substantial evidence pointing towards no effect.
The exception people cite is REDUCE-IT, which tested high-dose icosapent ethyl, a purified EPA preparation, in people with raised triglycerides already on statins, and found a substantial reduction in cardiovascular events. It is a real, large, well-conducted trial. It is also contested, principally because the placebo was mineral oil, which appeared to raise LDL cholesterol and inflammatory markers in the comparator group, potentially inflating the apparent benefit. A related trial, STRENGTH, used a different omega-3 formulation and a corn oil comparator and found no benefit, which sharpened the concern about the comparator. The field has not fully resolved this. What is clear is that REDUCE-IT tested a prescription drug at a high dose in a specific high-risk population, and it is not evidence for over-the-counter fish oil in a general population.
Why do the observations and the trials disagree?
This is the interesting part, and there are several plausible explanations that are not mutually exclusive.
Confounding is the obvious candidate. People who eat a lot of fish differ from people who do not, in income, education, overall diet quality, and health behaviours generally. Statistical adjustment reduces this but rarely eliminates it. If fish eating is a marker of an advantaged, health-conscious life, then the omega-3 index is partly measuring social class, and no capsule will replicate that.
Substitution is a subtler and rather compelling explanation. If you eat fish, you are not eating something else. In many populations that something else is processed meat or red meat, and the benefit attributed to fish may partly be the absence of what fish displaced, a point that connects to our red meat and mortality coverage. A supplement adds omega-3 without removing anything.
The food matrix argument is that fish delivers protein, selenium, iodine, vitamin D, and other components alongside EPA and DHA, and that the package may matter more than the isolated fatty acids. This is a recurring theme across nutrition, and it is why the whole-food evidence often outperforms the extracted-nutrient evidence.
Background changes matter too. Many of the older trials that showed benefit, including GISSI-Prevenzione in post-infarction patients in the 1990s, were conducted before statins, modern antiplatelet therapy, and revascularisation became routine. The benefit of adding omega-3 on top of contemporary optimal cardiovascular therapy is much harder to detect, and may genuinely be smaller, because the other treatments are doing the work.
And baseline status may matter. Trials in populations already consuming reasonable amounts of fish are testing supplementation in relatively replete people, which is a poor design for detecting a deficiency-correction effect. This is the same structural problem that has plagued vitamin D trials, discussed in vitamin D and mortality trials.
None of these explanations rescue the supplement. They mostly explain why the food looks good and the capsule does not.
Should you test your omega-3 index?
The honest answer is that it is a reasonable thing to do if you are curious, and it is unlikely to change your behaviour in a way that matters.
Consider what the possible results are. If your index comes back high, you eat fish, and you should carry on. If it comes back low, the recommended action is to eat more fish, which you should probably do regardless of the number. The test rarely produces information that changes a decision, which is the standard test of whether a test is worth doing.
There are narrower situations where it is more informative. Vegans and vegetarians, who cannot easily eat fish and whose ALA conversion is unreliable, may find a genuinely low reading useful in deciding whether an algal EPA and DHA supplement is worth taking, and it is one of the few groups where the deficiency-correction logic is strong. People taking supplements who want to know whether the product is doing anything, since supplement quality varies and oxidised fish oil is a documented problem, may find before-and-after testing useful. And people with a specific clinical reason, discussed with a clinician, may have a case.
Practical notes if you do test. Home finger-prick collection kits exist and the dried blood spot method is reasonably well validated for this measure. Because red cells integrate over months, timing relative to a meal does not matter, which is an advantage. Allow at least three to four months after any change in intake before retesting, since that is how long the membrane composition takes to reflect a new steady state.
What raises your omega-3 index?
Oily fish is the answer with the best evidence behind it. Salmon, mackerel, sardines, herring, anchovies, and trout are the standard list. Most guidance, including from the AHA and from UK dietary recommendations, converges on roughly two portions of fish per week with at least one being oily. That is a modest, achievable target and it is where the outcome evidence sits.
Supplements will raise the number reliably. Fish oil, krill oil, cod liver oil, and algal oil all work, and the index responds in a dose-dependent way. The question is not whether they raise the index. It is whether raising the index this way does anything, and the trial evidence says mostly not.
If you do supplement, a few practical points. Check the actual EPA and DHA content rather than the total oil weight, as a "1000 mg fish oil" capsule often contains only around 300 mg of combined EPA and DHA. Oxidation is a real issue: fish oil goes rancid, and analyses of retail products have repeatedly found oxidation levels exceeding recommended limits. A product that smells strongly fishy or causes fishy burps may be oxidised. Take it with a meal containing fat, since absorption improves substantially. Algal oil is the sensible route for vegans and has the side benefit of avoiding the sustainability and contaminant questions that come with fish oil.
Cod liver oil deserves a specific warning. It contains vitamin A as retinol, and at doses high enough to deliver meaningful EPA and DHA you can approach intakes of preformed vitamin A that are not advisable, particularly in pregnancy. It is not a good vehicle for high-dose omega-3.
Plant sources, flaxseed, chia, walnuts, and rapeseed oil, provide ALA. They are genuinely healthy foods, and our nuts and longevity piece covers walnuts specifically, but they will not raise your omega-3 index much because the conversion to EPA and especially DHA is poor.
Frequently Asked Questions
Should I take fish oil supplements? For most people at average risk, the evidence does not support it. A Cochrane review of the randomised trial literature concluded that omega-3 supplementation has little or no effect on all-cause mortality or cardiovascular events, and large trials including VITAL and ASCEND were neutral. The exceptions are narrower: people who cannot or will not eat fish, particularly vegans, where an algal supplement corrects a genuine shortfall, and specific clinical situations such as very high triglycerides where a prescription preparation may be considered with a doctor.
Is the omega-3 index better than a standard blood fatty acid test? Yes, meaningfully so, as a measure of habitual status. Plasma or serum fatty acid levels reflect recent meals and can swing dramatically depending on when you last ate fish. Red blood cell membranes incorporate fatty acids over the cell's roughly 120-day lifespan, so the index reflects months of intake rather than hours. If you are going to measure omega-3 status at all, the red cell index is the right way to do it.
Do vegans need to supplement omega-3? It is one of the more defensible supplement cases. Vegans have no dietary EPA or DHA, and conversion from plant-derived ALA is inefficient, particularly for DHA. Omega-3 index values in vegans are typically low. Whether that low value causes harm has not been established, since the trial evidence for benefit from raising it is weak in general populations. An algal oil supplement is inexpensive, low-risk, and addresses a genuine dietary gap, which is a reasonable basis for taking it even without proof of outcome benefit.
What about mercury and contaminants in fish? This is a real consideration but it is often overstated for the fish most relevant here. Mercury accumulates up the food chain, so large predatory fish such as shark, swordfish, marlin, and to a lesser degree tuna carry the highest levels. The small oily fish that are richest in EPA and DHA, sardines, anchovies, herring, mackerel, are short-lived and low in the food chain, and are correspondingly low in mercury. Specific advice applies for pregnancy and for young children, and national food safety agencies publish it.
How long does it take to change my omega-3 index? About three to four months to reach a new steady state, because red blood cells live roughly 120 days and the membrane composition only changes as cells turn over. You will see partial movement sooner, but there is no point retesting after a few weeks. If you change your intake and want to know the effect, wait at least three months before testing again.
Medical Disclaimer
This article is for general information only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for consultation with a qualified healthcare professional who knows your medical history. Biomarker results, including the omega-3 index, require clinical context to interpret and should not be acted on in isolation. Do not start, stop, or change any supplement on the basis of this content, and consult a clinician before doing so, particularly if you take anticoagulant or antiplatelet medication, since high-dose omega-3 may affect bleeding risk, or if you are pregnant or breastfeeding, where specific advice applies to both fish choice and vitamin A intake from cod liver oil. If you have symptoms that concern you, seek medical attention rather than relying on information found online.